These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2070537)
1. Carcinoembryonic antigen and head and neck cancer. Laarman DA; van Kamp GJ; Balm AJ; Braakhuis BJ; Snow GB Clin Otolaryngol Allied Sci; 1991 Apr; 16(2):182-6. PubMed ID: 2070537 [TBL] [Abstract][Full Text] [Related]
2. CEA levels in head and neck cancer. Silverman NA; Alexander JC; Chretien PB Cancer; 1976 May; 37(5):2204-11. PubMed ID: 1260711 [TBL] [Abstract][Full Text] [Related]
3. [CEA studies in squamous cell carcinomas of the head and neck]. Schröder M; Meyer T HNO; 1986 Aug; 34(8):334-42. PubMed ID: 3759515 [TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancer. Pectasides D; Bourazanis J; Economides N; Pozadzidou P; Gogou L; Koutsiouba P; Athanassiou A Int J Biol Markers; 1993; 8(2):81-7. PubMed ID: 8366300 [TBL] [Abstract][Full Text] [Related]
5. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [TBL] [Abstract][Full Text] [Related]
6. Serum SCC-Ag in head and neck squamous cell carcinoma. Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) on tissue sections from squamous cell head and neck cancer and plasma CEA levels of the patients. Yanagawa T; Hayashi Y; Nishida T; Yoshida H; Yura Y; Azuma M; Sato M Int J Oral Maxillofac Surg; 1986 Jun; 15(3):296-306. PubMed ID: 3088159 [TBL] [Abstract][Full Text] [Related]
8. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778 [TBL] [Abstract][Full Text] [Related]
9. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients. Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719 [TBL] [Abstract][Full Text] [Related]
10. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status. Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of plasma carcinoembryonic antigen (CEA) in patients with head and neck cancer: correlation with tissue CEA staining]. Kawasaki T; Nagamine T; Suzuki I; Shingaki S; Nakajima T; Suzuki M Gan No Rinsho; 1986 Feb; 32(2):133-40. PubMed ID: 2421023 [TBL] [Abstract][Full Text] [Related]
12. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093 [TBL] [Abstract][Full Text] [Related]
13. [Significance of the CEA-Test in malignomas of the head and neck (author's transl)]. Grossenbacher R Arch Otorhinolaryngol; 1979; 222(1):23-7. PubMed ID: 426719 [TBL] [Abstract][Full Text] [Related]
14. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck. Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547 [TBL] [Abstract][Full Text] [Related]
16. [The evaluation of carcinoembryonic antigen (CEA) levels in patients with laryngeal cancer]. Namysłowski G; Klimala J Otolaryngol Pol; 1998; 52(2):169-74. PubMed ID: 9673116 [TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas]. Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163 [TBL] [Abstract][Full Text] [Related]
19. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [TBL] [Abstract][Full Text] [Related]
20. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy. Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]